February 20 – 23, 2018
Taj Diplomatic Enclave
New Delhi, India
Join Treatment Action Group (TAG) and the Global Coalition of TB Activists (GCTA) for a webinar on how civil society and community groups can initiate a dialogue with their national governments in advance of the Ministerial Conference in Moscow. Panelists will debut new, community-developed outreach tools and share strategies to maintain an open channel for communication and accountability in the lead up to the UN High-Level Meeting on TB and beyond.
1) Jeffry Acaba, ACT Asia Pacific
2) Fanny Voitzwinkler, TB Europe Coalition
3) Sharonann Lynch, Médecins Sans Frontières
4) Timur Abdullaev, TB People
5) Anele Yawa, Treatment Action Campaign
Moderator: Marcus Low, Spotlight
Organized by DR-TB STAT
The symposium will provide an update on the UNITAID-funded endTB initiative and findings, including culture conversion and reversion and adverse events for the 600 people who have received bedaquiline or delamanid.
Evidence for treatment with newer DR-TB drugs, shorter treatment regimens, ambulatory care instead of hospitisation, and fast-track registration of new drugs.
Session will analyse the barriers to reducing costs and burden for people with drug-resistant TB including: decentralised and ambulatory treater, shorter treatment and newer drugs to reduce toxicity, and interventions to reduce out-of-pocket costs of treatment.